Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Silynxcom CEO Nir Klein Buys 50,149 Shares Over Three Days

Nir Klein, Chief Executive Officer and Director of Silynxcom Ltd. (NASDAQ:SYNX), filed a Form 4 on November 3, 2026, disclosing three open-market purchases of Ordinary Shares totaling 50,149 shares acquired between October 29 and November 2, 2026.

Nitish Kishor | 03 November 2026

Barry Hassett Acquires 253 BioStem Shares via RSU Vesting

BioStem Technologies, Inc. Chief Commercial Officer Barry Hassett filed a Form 4 on November 3, 2026, disclosing a transaction dated November 1, 2026, in which 253 shares of common stock were acquired through the vesting of restricted stock units at $0.00 per share.

Aditi Sarkar | 03 November 2026

Villamil Felix Gets 1,527 Restricted Shares at First BanCorp

Director Felix Villamil of First BanCorp /PR/ (NYSE:FBP) filed a Form 4 on November 3, 2026, disclosing two transactions in common stock dated October 30, 2026: a share withholding for tax purposes and a new restricted stock award.

Manish Choudhary | 03 November 2026

Rothblatt Exercises 9,500 Options, Sells Shares Nov. 2

Martine A. Rothblatt, Chairperson and CEO of United Therapeutics Corp (NASDAQ:UTHR), filed a Form 4 on November 3, 2026, disclosing the exercise of 9,500 stock options and the sale of 9,500 shares of common stock on November 2, 2026, pursuant to a pre-arranged 10b5-1 …

Vinay Lochav | 03 November 2026

Sheehan Transfers 39,495 Dave & Buster's Shares to GRAT

Director Kevin M. Sheehan filed a Form 4 with the SEC on November 3, 2026, disclosing a transfer of 39,495 shares of Dave & Buster's Entertainment, Inc. common stock to a grantor retained annuity trust on November 2, 2026.

Anjali Anand | 03 November 2026

XPO COO Bates Sells 2,615 Shares on November 2, 2026

David J. Bates, Chief Operating Officer of XPO, Inc., filed a Form 4 on November 3, 2026, disclosing the sale of 2,615 shares of XPO common stock on November 2, 2026, under a pre-established Rule 10b5-1 trading plan.

Aditi Sarkar | 03 November 2026

Director Clarke Buys 21,800 LKQ Shares at $18.35

Director Andrew C. Clarke filed a Form 4 with the SEC on November 3, 2026, disclosing a purchase of LKQ Corp common stock on October 30, 2026.

Shwetambri Chauhan | 03 November 2026

LKQ Director Powell Buys 10,000 Shares at $19.15

Director Michael Scott Powell filed a Form 4 with the SEC on November 3, 2026, disclosing a purchase of 10,000 shares of LKQ Corp common stock on November 2, 2026.

Aakashdeep | 03 November 2026

Christmas Receives 34,722-Share RSU Grant at REGENXBIO

Patrick J. Christmas, Chief Strategy and Legal Officer of REGENXBIO Inc., reported the acquisition of 34,722 shares of common stock underlying a time-based restricted stock unit award, with a transaction date of November 1, 2026, in a filing submitted November 3, 2026.

Manish Choudhary | 03 November 2026

Mitchell Chan Gets 24,305-Share RSU Grant at REGENXBIO

REGENXBIO Inc. Chief Financial Officer Mitchell Chan filed a Form 4 on November 3, 2026, disclosing the acquisition of 24,305 shares of common stock underlying a time-based restricted stock unit award, with a transaction date of November 1, 2026.

Shwetambri Chauhan | 03 November 2026
Support

Hi! How can we help you today?

Loading…